Atomo Diagnostics Ltd (AT1) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.145x

Based on the latest financial reports, Atomo Diagnostics Ltd (AT1) has a cash flow conversion efficiency ratio of -0.145x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-962.50K ≈ $-681.03K USD) by net assets (AU$6.64 Million ≈ $4.70 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See AT1 equity financing ratio to measure how much of total assets are equity-financed.

Atomo Diagnostics Ltd - Cash Flow Conversion Efficiency Trend (2017–2025)

This chart illustrates how Atomo Diagnostics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore Atomo Diagnostics Ltd (AT1) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Atomo Diagnostics Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Atomo Diagnostics Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Ecomiam SA PA:ALECO	-0.357x
XINYUAN REAL ESTATE ADR20 F:3XR	N/A
IDT Australia Ltd AU:IDT	-0.047x
Niobay Metals Inc V:NBY	-0.432x
Hookipa Pharma Inc NASDAQ:HOOK	-0.249x
TwentyFour Income Fund Ltd LSE:TFIF	0.015x
Compucom Software Limited NSE:COMPUSOFT	0.261x
Greentech Metals Ltd AU:GRE	-0.056x

Annual Cash Flow Conversion Efficiency for Atomo Diagnostics Ltd (2017–2025)

The table below shows the annual cash flow conversion efficiency of Atomo Diagnostics Ltd from 2017 to 2025. For the full company profile with market capitalisation and key ratios, see AT1 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$6.98 Million ≈ $4.94 Million	AU$-1.96 Million ≈ $-1.39 Million	-0.281x	+39.57%
2024-06-30	AU$10.08 Million ≈ $7.14 Million	AU$-4.69 Million ≈ $-3.32 Million	-0.465x	-17.53%
2023-06-30	AU$14.79 Million ≈ $10.47 Million	AU$-5.85 Million ≈ $-4.14 Million	-0.395x	-249.55%
2022-06-30	AU$24.81 Million ≈ $17.56 Million	AU$-2.81 Million ≈ $-1.99 Million	-0.113x	+19.46%
2021-06-30	AU$30.09 Million ≈ $21.29 Million	AU$-4.23 Million ≈ $-2.99 Million	-0.140x	+22.67%
2020-06-30	AU$34.48 Million ≈ $24.40 Million	AU$-6.26 Million ≈ $-4.43 Million	-0.182x	-154.05%
2019-06-30	AU$-5.47 Million ≈ $-3.87 Million	AU$-1.84 Million ≈ $-1.30 Million	0.336x	-70.46%
2018-06-30	AU$-4.89 Million ≈ $-3.46 Million	AU$-5.56 Million ≈ $-3.93 Million	1.137x	+101.03%
2017-06-30	AU$47.82K ≈ $33.83K	AU$-5.26 Million ≈ $-3.72 Million	-109.899x	--

About Atomo Diagnostics Ltd

AU:AT1 Australia Medical Devices

Market Cap

$11.48 Million

AU$16.22 Million AUD

Market Cap Rank

#26694 Global

#1244 in Australia

Share Price

AU$0.02

Change (1 day)

+5.88%

52-Week Range

AU$0.02 - AU$0.04

All Time High

AU$0.57